19.92
전일 마감가:
$19.80
열려 있는:
$19.86
하루 거래량:
33,668
Relative Volume:
0.07
시가총액:
$400.17M
수익:
$66.98M
순이익/손실:
$9.65M
주가수익비율:
41.49
EPS:
0.48
순현금흐름:
$10.19M
1주 성능:
-2.44%
1개월 성능:
+13.60%
6개월 성능:
-24.51%
1년 성능:
-34.82%
Simulations Plus Inc Stock (SLP) Company Profile
명칭
Simulations Plus Inc
전화
661-723-7723
주소
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
SLP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SLP
Simulations Plus Inc
|
19.86 | 398.86M | 66.98M | 9.65M | 10.19M | 0.48 |
|
VEEV
Veeva Systems Inc
|
229.88 | 37.67B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
72.92 | 13.36B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
44.59 | 8.48B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
97.65 | 8.18B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.88 | 6.35B | 11.99B | 24.18M | 234.31M | 0.2956 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | TD Cowen | Hold |
| 2025-07-15 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-11-15 | 개시 | Stephens | Overweight |
| 2024-07-29 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-07-16 | 개시 | JMP Securities | Mkt Perform |
| 2024-06-28 | 개시 | William Blair | Outperform |
| 2023-05-09 | 개시 | BTIG Research | Buy |
| 2021-10-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2021-01-12 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-10-16 | 개시 | Raymond James | Outperform |
| 2020-09-08 | 개시 | Oppenheimer | Outperform |
| 2020-01-06 | 개시 | Craig Hallum | Buy |
모두보기
Simulations Plus Inc 주식(SLP)의 최신 뉴스
Simulations Plus (NASDAQ:SLP) Updates FY 2026 Earnings Guidance - MarketBeat
Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - marketscreener.com
Russell Investments Group Ltd. Sells 112,542 Shares of Simulations Plus, Inc. $SLP - MarketBeat
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Adva - pharmiweb.com
Simulations Plus responds to FDA draft guidance on antibody testing - Investing.com
Simulations Plus responds to FDA draft guidance on antibody testing By Investing.com - Investing.com South Africa
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - The AI Journal
Simulations Plus: Solid Platform, Soft Outlook (Rating Upgrade) - Seeking Alpha
Simulations Plus amends executive employment agreements with new compensation terms - Investing.com
Kennedy Capital Management LLC Sells 84,846 Shares of Simulations Plus, Inc. $SLP - MarketBeat
Simulations Plus urges attendance for PBPK regulatory webinar - Traders Union
How sustainable is Simulations Plus Inc. stock dividend payoutMarket Risk Analysis & Weekly High Potential Stock Alerts - Newser
Why Shares of Simulations Plus Soared This Week - The Globe and Mail
Simulations Plus (NASDAQ:SLP) Shareholders Are up 18% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛
William Blair Raises Earnings Estimates for Simulations Plus - MarketBeat
Why Simulations Plus Inc. stock could benefit from AI revolution2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser
Simulations Plus Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Simulations Plus' Q4 Earnings & Sales Meet Estimates, Fall Y/Y - sharewise.com
Why Simulations Plus Stock Was Soaring Today - Finviz
Simulations Plus: Buying On Long-Term Silico Drug-Development - Seeking Alpha
Simulations Plus (SLP) Q3 $67M Net Loss Tests Market’s High-Growth Profitability Narrative - simplywall.st
Insider Sell: Lisa Lavange Sells Shares of Simulations Plus Inc (SLP) - GuruFocus
Simulations Plus (NASDAQ:SLP) Issues Quarterly Earnings Results - MarketBeat
Simulations Plus Q4 2025 Earnings Preview - MSN
Simulations Plus Climbs On Earnings Strength, Biotech Market ReboundSimulations Plus (NASDAQ:SLP) - Benzinga
Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound - Sahm
Simulations Plus (SLP) Poised to Benefit from New FDA Guidance - GuruFocus
Simulations Plus Reports Q4 2025 Financial Results - MSN
Simulations Plus Posts Strong Q4 Results, Joins Credo Technology Group, United Natural Foods, Boeing And Other Big Stocks Moving Higher On Tuesday - Benzinga
Simulations Plus announces webinar on new GPX.2 P-PSD module - Traders Union
Simulations Plus Q4 Revenue Slips; Reaffirms FY26 Guidance; Stock Down - Nasdaq
Will Simulations Plus Inc. stock maintain dividend yieldIPO Watch & Risk Managed Investment Signals - Newser
Citizens maintains Market Perform rating on Simulations Plus stock By Investing.com - Investing.com Canada
Simulations Plus outlines $79M–$82M FY 2026 revenue target as AI and cloud integration strategy advances - MSN
Simulations Plus Inc (SLP) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ... By GuruFocus - Investing.com Canada
Simulations Plus Inc (SLP) Q4 2025 Earnings Call Highlights: Nav - GuruFocus
Simulations Plus Inc (SLP) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ... - Yahoo Finance
Simulations Plus: Fiscal Q4 Earnings Snapshot - New Haven Register
Simulations Plus (SLP) Reports Fiscal 2025 Growth Amid Market Ch - GuruFocus
Simulations Plus earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Simulations Plus Q4 Earnings: Loss Reported, Full-Year Outlook ProvidedNews and Statistics - IndexBox
Simulations Plus Fiscal Q4 Earnings, Revenue Fall; Reaffirms 2026 Guidance - marketscreener.com
Simulations Plus shares jump 5% on upbeat FY26 guidance, despite revenue miss - Investing.com Nigeria
Simulations Plus (SLP) Surpasses Q4 Revenue Expectations - GuruFocus
Simulations Plus (SLP) Projects Strong Revenue Growth for FY26 - GuruFocus
Simulations Plus shares jump 5% on upbeat FY26 guidance, despite revenue miss By Investing.com - Investing.com South Africa
Simulations Plus, Inc. SEC 10-K Report - TradingView
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results - Business Wire
(SLP) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Simulations Plus (SLP) Expected to Announce Strong Q4 Earnings - GuruFocus
Simulations Plus Inc (SLP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):